We've wondered for centuries whether knowledge is latent and innate or learned and grasped through experience, and a new ...
Enthusiasm doesn’t always lead to clear-eyed risk assessment or strategic usage plans, leaving companies vulnerable to ...
The FDA approved imlunestrant for treatment of certain adults with breast cancer who experience disease progression after at least one prior line of endocrine therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback